Cardinal Capital Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 878 filers reported holding NOVARTIS A G in Q2 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.

Quarter-by-quarter ownership
Cardinal Capital Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$4,247,053
+3.0%
41,695
+2.0%
0.86%
+4.1%
Q2 2023$4,125,100
+8.2%
40,879
-1.4%
0.83%
+5.1%
Q1 2023$3,812,756
+1.2%
41,443
-0.2%
0.79%
-1.4%
Q4 2022$3,768,781
+18.5%
41,543
-0.7%
0.80%
+6.5%
Q3 2022$3,180,000
-11.2%
41,840
-1.3%
0.75%
-8.2%
Q2 2022$3,583,000
-3.1%
42,386
+0.6%
0.82%
+9.6%
Q1 2022$3,697,000
+4.3%
42,136
+4.0%
0.75%
+6.6%
Q4 2021$3,544,000
+7.4%
40,521
+0.4%
0.70%
-1.8%
Q3 2021$3,300,000
-10.1%
40,352
+0.3%
0.72%
-7.7%
Q2 2021$3,669,000
+8.0%
40,213
+1.2%
0.78%
+3.5%
Q1 2021$3,398,000
-7.6%
39,747
+2.0%
0.75%
-14.0%
Q4 2020$3,679,000
+10.9%
38,958
+2.1%
0.87%
-4.7%
Q3 2020$3,317,000
+0.4%
38,148
+0.8%
0.91%
-3.9%
Q2 2020$3,305,000
-7.5%
37,849
-12.7%
0.95%
-19.4%
Q1 2020$3,574,000
-13.5%
43,352
-0.7%
1.18%
+10.0%
Q4 2019$4,134,000
+8.3%
43,662
-0.6%
1.07%
+1.8%
Q3 2019$3,817,000
-4.8%
43,932
+0.0%
1.05%
-7.4%
Q2 2019$4,011,000
-5.6%
43,924
-0.6%
1.14%
-6.3%
Q1 2019$4,248,000
+12.7%
44,189
+0.6%
1.21%
-2.3%
Q4 2018$3,770,000
+1.3%
43,936
+1.7%
1.24%
+18.0%
Q3 2018$3,721,000
+14.1%
43,197
+0.1%
1.05%
+6.7%
Q2 2018$3,261,000
-6.0%
43,166
+0.6%
0.99%
-9.4%
Q1 2018$3,470,000
-3.1%
42,923
+0.6%
1.09%
+0.6%
Q4 2017$3,582,000
-2.3%
42,664
-0.1%
1.08%
-6.4%
Q3 2017$3,668,000
+14.7%
42,727
+11.5%
1.16%
+9.6%
Q2 2017$3,198,000
+38.4%
38,319
+23.2%
1.06%
+26.4%
Q1 2017$2,310,000
+11.3%
31,099
+9.2%
0.84%
+5.8%
Q4 2016$2,075,000
-21.4%
28,486
-14.8%
0.79%
-23.7%
Q3 2016$2,639,000
-2.3%
33,424
+2.1%
1.04%
-5.7%
Q2 2016$2,702,000
+17.5%
32,752
+3.2%
1.10%
+13.7%
Q1 2016$2,300,000
+2.2%
31,745
+21.3%
0.97%
-3.9%
Q4 2015$2,251,000
-9.5%
26,163
-3.3%
1.00%
-13.6%
Q3 2015$2,487,000
-5.3%
27,061
+1.3%
1.16%
+1.4%
Q2 2015$2,627,000
+13.3%
26,713
+13.6%
1.15%
+17.2%
Q1 2015$2,319,000
+15.5%
23,521
+8.6%
0.98%
+6.6%
Q4 2014$2,007,000
+4.5%
21,658
+6.2%
0.92%
+0.5%
Q3 2014$1,920,000
+12.6%
20,398
+8.3%
0.91%
+7.9%
Q2 2014$1,705,000
-17.8%
18,839
-22.7%
0.85%
-20.7%
Q1 2014$2,073,000
+11.9%
24,383
+5.8%
1.07%
+12.3%
Q4 2013$1,853,000
+5.2%
23,055
+0.4%
0.95%
-5.0%
Q3 2013$1,761,000
+7.6%
22,963
-0.7%
1.00%
+3.3%
Q2 2013$1,636,00023,1330.97%
Other shareholders
NOVARTIS A G shareholders Q2 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders